Literature DB >> 34339873

Advances in cell death - related signaling pathways in acute-on-chronic liver failure.

Liqiao Huang1, Jie Liu2, Caiqun Bie3, Helu Liu3, Yichun Ji4, Dongfeng Chen5, Meiling Zhu6, Weihong Kuang7.   

Abstract

Acute-on-chronic liver failure (ACLF) has been a hot spot in the field of liver disease research in recent years, with high morbidity, rapid course change and high mortality. Currently, there is the absence of specific treatment in clinical practice. Liver transplantation has the best therapeutic effect, but it is prone to have internal environment disorder and liver cell death after transplantation, which leads to the failure of transplantation.In recent years, with the development of molecular biology, scholars have explored the treatment of ACLF at the molecular level, and more and more molecular signaling pathways related to the treatment of ACLF have been discovered. Modulating the relevant signaling pathways to reduce the mortality of liver cells after transplantation may effectively improve the success rate of transplantation. In this review, we introduce some signaling pathways related to cell death and their research progress in acute-on-chronic liver failure.
Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  ACLF; Cell death; Ferroptosis; Signaling pathway

Mesh:

Year:  2021        PMID: 34339873     DOI: 10.1016/j.clinre.2021.101783

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  1 in total

1.  Plasma Interleukin-6 Level: A Potential Prognostic Indicator of Emergent HBV-Associated ACLF.

Authors:  Zhe-Bin Wu; Yu-Bao Zheng; Ke Wang; Zhi-Shuo Mo; Xu Zhen; Ying Yan; Zhi-Liang Gao
Journal:  Can J Gastroenterol Hepatol       Date:  2021-11-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.